CurveBeam (ASX:CVB) recently reported their fiscal year revenues from ordinary activities, which stands at A$8.1 million.
However, the company ended the year with a net loss attributable to A$52.0 million, a significant increase compared to last year’s loss of A$8.5 million.
CurveBeam is a multinational manufacturer of diagnostic equipment designed to provide high-resolution weight bearing CT images.